EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Toward Closed-Loop Cognitive Modulation in Alzheimer’s Disease: BCI-Relevant Evidence and a Translational Roadmap

Aging and Disease · 2026

DOI: 10.14336/ad.2026.11026 ↗
AbstractBibliografische Angaben

Abstract

Alzheimer’s disease (AD) has entered a biomarker-defined era, yet most cognitive and neuromodulatory interventions continue to use fixed targets, timing, and doses. This targeted narrative review maps brain-computer interface (BCI) and closed-loop-relevant evidence in AD and mild cognitive impairment (MCI) by examining how sensing, control, and intervention modules are used prospectively. Read modules include electroencephalography (EEG), functional near-infrared spectroscopy (fNIRS), real-time functional magnetic resonance imaging (fMRI), functional ultrasound (fUS) and transcranial ultrasound localization microscopy (t-ULM), and digital measures. Control functions include feature extraction, within-person state decoding, uncertainty-aware decision rules, target-engagement assessment, and safety oversight. Write modules include neurofeedback, sensory gamma and sleep-phase acoustic stimulation, transcranial alternating-current stimulation (tACS), transcranial direct-current stimulation (tDCS), repetitive transcranial magnetic stimulation (rTMS), transcranial pulse stimulation (TPS), transcranial ultrasound stimulation (TUS), transcranial photobiomodulation (tPBM), and focused ultrasound-mediated blood-brain barrier (FUS-BBB) opening. Human studies have separately demonstrated signal-contingent feedback, individualized targeting, physiological target engagement, home delivery, and emerging sensing, while preclinical studies provide mechanistic support for gamma, optical, and ultrasound approaches. Sleep-phase acoustic stimulation additionally demonstrates early automated signal-to-stimulus control. Passive sensing provides observations, personalization sets baseline parameters, state-informed control uses current signals to alter delivery, and target engagement verifies the proximal response without establishing clinical efficacy. Reliable decoding of waking cognitive states, broader controller utility, and durable clinical benefit remain unvalidated. We therefore organize the field around disease context, state sensing, feature extraction, state decoding, bounded decision/intervention, response verification, and safety oversight. The decisive early design compares assignments to an adaptive policy with otherwise matched fixed delivery; a sham arm can additionally test intervention efficacy. Such trials must prespecify decoder calibration, uncertainty, abstention, safety limits, and mechanistic and clinical endpoints. Closed-loop cognitive modulation therefore defines a translational research agenda for AD.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →